Milrinone

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Milrinone and local guidelines before prescribing.

Inodilator

Mechanism

Phosphodiesterase-3 inhibitor.

Uses

Acute heart failure with low output.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Hypotension, arrhythmias, thrombocytopenia.

Interactions

Other inotropes.

Contraindications and cautions

Severe aortic stenosis

Monitoring

BP, ECG

Pregnancy and breastfeeding

Use if essential

Renal and hepatic impairment

Reduce dose in renal impairment

Overdose and reversal

Supportive

Special advice

Used when on beta-blockers; reduce dose in renal impairment.

More from the textbook: uses, cautions and other points
Where it is discussed in the book